The first BioPhoT call for Research and Innovation Projects (RIPs) received more than 120 RIP applications: scientists and industry from the biomedical, medical technology, pharmaceutical, photonics, smart materials and engineering areas of the Smart Specialisation Strategy or RIS3 had the opportunity to apply for a share of the total €6 million national funding. In the first round, which took place from 26 to 28 May, an independent panel of experts analysed the innovative potential and market relevance of the ideas submitted.
The experts highlighted that the technological diversity and thematic coverage of the applications reflect Latvia's scientific potential and are in line with the BioPhoT programme's aim to support early-stage technologies with high commercialisation potential in different scientific and economic sectors.
In the second round of PIP evaluation, 79 projects will be able to continue the competition for funding, followed by a scientific evaluation of the project applications by a panel of experts from the Latvian Science Council. The PIPs that will receive public funding in the first BioPhoT call will be announced in September.
Photo by Reinis Lindards Rozītis, RTU
